Treatment Strategy Based on Multimodal Management Outcome of Cavernous Sinus Dural Arteriovenous Fistula (CSDAVF) by Choi, Byung Se et al.
6 Neurointervention 6, February 2011
1Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea
2Department of Radiology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea
(A080201).
Received August 23, 2010; 
accepted after revision November 20, 2010.
Correspondence to: Dae Chul Suh, MD, Department of Radiology, Asan Medical Center, University of Ulsan, College of Medicine, 86
Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, Korea.
Tel. 82-2-3010-4366    Fax. 82-2-476-0090    E-mail: dcsuh@amc.seoul.kr
Neurointervention 2011;6:6-12
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,
provided the original work is properly cited. 
Original Paper
Treatment Strategy Based on Multimodal
Management Outcome of Cavernous Sinus Dural
Arteriovenous Fistula (CSDAVF)
Byung Se Choi, MD
1 ,2, Jee Won Park, MD
1, Jong Lim Kim, MD
1, Sung Youn Kim, MD
1, 
Yang Shin Park, MD
1, Heon-Ju Kwon, MD
1, Deok Hee Lee, MD
1, Dae Chul Suh, MD
1
DOI: 10.5469/neuroint.2011.6.1.6
Purpose: Angiographic finding including venous drainage pattern should be correlated to the present-
ing symptom pattern (SxP) in CSDAVF. We present outcome of CSDAVF management and suggest a
strategy according to SxP and type of treatment based on our experience.
Materials and Methods: We evaluated SxP, angiographic type (proliferative, restrictive or late restric-
tive), mode of treatment (embolization, Gamma Knife Radiation (GKR) or conservative manage-
ment), mode of embolization (transarterial or transvenous), and final clinical status (cure, improve-
ment, aggravation or no change). Ninety consecutive patients were included from a prospective
database. The mean follow-up was 17 months. We compared the outcomes according to SxP,
angiographic type, mode of treatment, and embolization using the chi-square or Fisher’s exact test.
Results: Ninety patients with 34 proliferative, 40 restrictive, and 16 late restrictive types of CSDAVF were
treated by embolization (n = 63), GKR (n = 7), and conservative management (n = 20). Cure or
improvement was 91% after embolization, 88% after conservative management, and 72% after GKR.
Following embolization, 100% of 24 proliferative types, 87% of 30 restrictive types, and 90% of 10
late restrictive types were cured or improved. Cure or improvement after transvenous embolization
was 98% (43/44) compared with 88% (15/17) after transarterial embolization (p = 0.003).
Conclusion: Various factors of SxP, angiographic type, and mode of treatment should be considered in
order to obtain a more favorable outcome for patients with CSDAVF. Embolization via venous
approach tended to result in a more complete cure than that via arterial approach.
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Transvenous embolizationAmong dural arteriovenous fistulas (DAVFs) with an
abnormal direct connection between a meningeal artery
and a meningeal vein or dural venous sinus, cavernous
sinus dural arteriovenous fistula (CSDAVF) differs in
several aspects from DAVF involving other dural
sinuses (1). Anatomically, the cavernous sinus (CS) is
an extradurally located sinus while other dural sinuses
are located between two dural walls in the cranial
cavity. Compared with the transverse-sigmoid sinus as
the most frequent site of occurrence in western
countries, the CS is the most common location of
DAVF in Asians (2-4).
CSDAVF presents with three distinctive angiographic
patterns, i.e. the proliferative type (PT), restrictive type
(RT), and late restrictive type (LRT) related to the four
presenting symptom patterns (SxP) of orbital SxP,
cavernous SxP, ocular SxP, and cerebral SxP according
to the status of the CS confluence (5). This concept
associated with the presenting SxP and the CS venous
drainage patterns provided a practical basis for assess-
ing the disease status and for planning therapeutic
decisions (5). Progressive restrictive change of the
venous drainage of the angiographic type in CSDAVF
cannot only affect the presenting SxP, but can also
modify the strategy regarding the choice of treatment
modality.
The treatment options for these lesions include
conservative management such as manual compression
of the ipsilateral carotid artery, transarterial and/or
transvenous embolization, and Gamma Knife Radiation
(GKR). Some authors prefer endovascular therapy as
the primary treatment, whereas others recommend
conservative management or even radiation-induced
obliteration.  
The clinical SxP and signs of CSDAVF are usually
known to be benign as CS has sufficient venous
drainage routes including the superior ophthalmic vein
(SOV), inferior and superior petrosal sinuses (IPS and
SPS), superficial middle cerebral vein (SMCV), and
the coronary sinus on the opposite side of the CS (5).
As the symptoms of CSDAVF are very diverse and
fluctuate, analysis of the symptomatology related to the
angiographic findings does not always correspond to
the disease status, and therefore the optimal treatment
for CSDAVF is not immediately obvious. Furthermore,
although most studies report an immediate functional
outcome after treatment, few have been reported
according to the long-term patient status. We evaluated
and compared the outcome of CSDAVF according to
the SxP and type of treatment in order to propose a




We retrospectively analyzed 90 consecutive patients
with CSDAVF in the prospectively collected database
between May 1991 and July 2007 during the mean 17-
month follow-up period. Patient age ranged from 20 to
80 years (mean 57; male-to-female ratio, 24:66).
Written informed consent for the therapy was obtained
from each patient and their family after the procedure
had been fully explained. This study was approved by
our institutional review board.
Based on the cerebral angiographic findings, we
defined the disease as proliferative, restrictive or late
restrictive type and patient symptoms as having an
orbital, cavernous, ocular or cerebral symptom pattern,
as previously described (5). The proliferative type (PT)
revealed numerous arterial feeders to CS. Arterial
feeders, especially from the middle meningeal artery
and ophthalmic artery, converge around CS in addition
to the dural branches of ICA. The number of feeders
was not quantified because of many feeders with small
size and large number. There was a large amount of
arteriovenous shunt (AVS), and the shunt flow was
relatively rapid while filling CS as well as the
antegrade and retrograde venous routes. The venous
phase showed well-preserved antegrade flow into IPS.
Both CSs usually filled completely with the shunted
flow regardless of the involved side of CS. There was a
bulging in the sinus wall because of the shunted venous
flow. The restrictive type (RT) showed multiple arterial
feeders, but not as many as the number of arterial
feeders in PTs. Differentiation between PT and RT was
that each arterial feeder converging to the wall of the
dilated CS could be delineated in RT but not in PT. The
venous phase showed obliteration of antegrade flow
most commonly of IPS and opening of retrograde flow
into SOV and/or cortical veins. AVS still existed,
although the flow was not as rapid as in PT. CS wall
margin was not delineated completely because of
deformity (loss of normal sinus contour) and lobulation
of CS wall. Such lobulated change of CS margin
seemed to be caused by a deformed outline of the sinus
wall caused by fibrosis or change caused by organizing
thrombosis (6-8). The late restrictive type (LRT)
showed only a few arterial feeders with sluggish
retrograde venous flow. Constrictive change (pruning)
of the draining veins in the retrograde venous outflow
was the outstanding feature of this type. There was
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venous phase. Such sluggish venous outflow seemed to
be related to the constrictive venous change caused by
the long-standing elevated venous pressure. 
The orbital symptom pattern (OrbSxP) was caused by
the retrograde venous flow and/or pressure from CS
including chemosis, exophthalmos, periorbital pain,
and eyelid swelling. The cavernous symptom pattern
(CavSxP) included ptosis, diplopia, anisocoria, and
ophthalmoplegia caused by cranial nerve deficits that
seemed to be related to bulging or elevated pressure of
CS and/or perhaps to the steal phenomenon of blood
supply to the cranial nerves (9). The ocular symptom
pattern (OcuSxP) related to increased venous pressure
draining the eyeball was decreased vision (when there
is a patient symptom or interocular difference of > 0.2,
i.e., 2 lines difference in the Snellen visual acuity chart
or its equivalent), increased intraocular pressure (> 20
mm Hg or a interocular difference of > 5 mm Hg),
severe ocular (eyeball) pain, glaucoma, and retinal
hemorrhage. The cerebral symptom pattern (CerSxP)
was related to reflux of AVS into SMCV or of the
petrosal vein into the perimesencephalic vein and
cerebellar vein, thus leading to infarction or venous
congestion in the basal ganglia, brain stem, or cerebel-
lum leading to seizure or to hemorrhage.
The presenting SxP of the CSDAVFs were cavernous
in 63 patients (70%), orbital in 54 patients (60%),
ocular in 53 patients (59%), and cerebral in six patients
(7%), according to the order of frequency. Ninety
patients revealed 34 proliferative, 40 restrictive, and 16
late restrictive angiographic types. Of 34 patients with
the PT, 24 underwent embolization, one GKR, and nine
patients had conservative treatment. Of the 40 patients
with the RT, 30 underwent embolization, five GKR,
and five patients had conservative treatment. Of the 16
patients with the LRT, 10 underwent embolization, one
GKR, and five patients had conservative treatment.
Overall, transarterial or transvenous embolization
was done in 63 patients (71%), GKR in 7 patients (8%)
and conservative management in 20 patients (21%). Of
the 63 patients treated by embolization, 44 underwent
transvenous embolization, 19 underwent transarterial
embolization, and 14 underwent both routes of
embolization during 81 procedures. If the first mode of
embolization failed or was incomplete and the next
mode of embolization could lead to total obliteration of
the DAVF, we regarded the last embolization route as
the main route of embolization.
Treatment and Follow-up
General approaches for the treatment of CSDAVF
include transarterial or transvenous embolization,
GKR, and conservative management. The benign
nature of the symptom category, such as orbital SxP, is
frequently associated with CSDAVFs, failure of the
main route of embolization or patient refusal of
treatment. Therefore, some DAVFs can be treated
conservatively together with manual compression
performed by the patient with instructions to compress
the carotid artery with their contralateral hand for 10-
30 seconds per compression six times an hour while
awake (10).
Embolization included both transarterial and transve-
nous approaches. The transarterial approach to the
external carotid artery was performed via the femoral
artery in order to obliterate the arteries feeding the
fistula, and using the coaxial technique. Polyvinyl
alcohol particles (150-500 μ m) were used as the main
embolic material. The transvenous approach was
performed via the inferior or superior petrosal sinus or
via the facial vein. We preferred transvenous approach
via the inferior petorsal sinus even if there was
occlusion of the inferior petrosal sinus in the restrictive
or late restrictive type. If the transvenous approach
failed, an approach from the contralateral side was also
attempted (Fig. 1). We used direct puncture via the
SOV when use of the transfemoral venous approach
was not possible. After the transvenous route to the
fistula was secured, we used non-detachable and/or
detachable coils to obliterate the fistula.
Angiographically, total occlusion was defined as
complete occlusion of the AVF, subtotal occlusion as a
small residual stagnant shunt that was considered likely
to thrombose, and partial occlusion as the presence of
residual fistula. Total and subtotal occlusions were
considered as successful treatment results.
Clinical follow-up was primarily obtained by both
interventional neuroradiologist and neurologist. In case
of any delay in patient recovery or a clinical suspicion
of recurrent disease, the imaging study was repeated.
The final clinical status was defined as cure or
improvement of the symptoms related to the lesion or
no change of symptoms and aggravation as newly
developed symptoms or aggravated status of pre-
existing symptoms detected during follow-up. We
compared each group’s outcomes according to the
SxPs, angiographic types, treatment types, and
embolization routes using the chi-square test or
Fisher’s exact test.
8 Neurointervention 6, February 2011
Byung Se Choi, et al.Neurointervention 6, February 2011 9
Outcome of Cavernous Sinus Dural Arteriovenous Fistula
AB
Fig. 1. A 68-year-old female presented with chemosis, exophthalmos, diplopia, and ocular pain on both sides. Her occluar pressure was
33/33 mmHg (right/left). (A) Left internal carotid arterigram shows a dural arteriovenous fistula in the cavernous sinus. Microcatheter
angiogram showed that both dilated cavernous sinuses were filled on the anterioposterior view (B) after a venous approach through the
right inferior petrosal sinus into the left cavernous sinus as well as into the fistular pouch as seen on the lateral view (C). (D) The final left
internal carotid arteriogram revealed that complete devascularization was achieved after coil embolization of the fistular pouch. On the
two-month follow-up, the patient’s symptoms and signs had completely disappeared and her ocular pressure had returned to normal
(15/14 mmHg).
CDRESULTS
The baseline demographic characteristics are
presented in Table 1. The mean age at diagnosis was 56
years (range, 17-85 years). The mean follow-up
interval was 17 months. Sixty-six patients (73%) were
women and 24 were men. The cure and improvement
rates were 95% (58/61), respectively, after emboliza-
tion, 83% (5/6) after GKR, and 78% (14/18) after
conservative treatment. Following embolization,
angiographic total occlusion was achieved in 50
patients, subtotal in six, and partial in seven patients.
The final clinical status revealed that 100% of 24 PTs,
87% of 30 RTs, and 90% of 10 LRTs were cured or
improved. No statistically significant difference was
found in the distribution of SxPs between the
angiographic types or in the outcomes according to the
SxPs.
In patients who underwent transvenous embolization,
the cure and improvement rates were 98% (43/44),
respectively, compared with 88% (15/17) in patients
who underwent transarterial embolization (p = 0.003)
(Table 1).
DISCUSSION
Our study, which was based on a single large referral
center experience, reveals that overall outcome of
CSDAVF treatment was better after embolization than
after conservative management and GKRS. In addition,
transvenous embolization achieved a cure and
improved states more commonly than arterial
embolization. This finding was similar to the treatment
results for DAVF seen in the literature (11). However,
the treatment strategy should focus on both the
patient’s symptom pattern and the angiographic
findings including the venous drainage pattern which
can affect the decision regarding the treatment
modality. Therefore, a simple comparison of the
outcomes among treatment modalities must be
carefully analyzed. There sometimes exist some
therapeutic dilemma in decision making in patients
with CSDAVF those have benign symptom but
posterior fossa and/or cortical venous drainage. When
embolization is used with the CSDAVF treatment,
embolization via a transvenous approach is currently
considered a good therapeutic option for patients with
cortical venous drainage or malignant symptoms such
as ocular and cerebral symptoms (5).
Conservative management can be offered in patients
with benign symptom category and embolization in
patients in the malignant symptom category. However,
some patients (about 4%) can progress to malignant
symptom category during follow-up period which
finally can reveal cortical venous drainage (12). Our
results can explain in some aspect such angiographic
progression leading to more malignant symptom
category possibly change into restrictive or late restric-
tive venous drainage pattern. In addition to the present-
ing symptom pattern, therefore, angiographic type
including the venous drainage pattern into the cortical
veins or posterior fossa veins is critical for deciding the
optimal treatment modality as well as the approach
route for the embolization. In the restrictive phase in
which the antegrade venous route is occluded, a
transvenous approach can be through the occluded
sinus or facial vein or through the SOV. Even though
such venous approach techniques are highly dependent
on the operator’s expertise because incomplete or
inappropriate embolization can carry the subsequent
risk of a rerouting phenomenon of residual venous
drainage which can lead to fatal hemorrhage or venous
infarction (13).
As steel coils and sclerosing liquid injections into the
CS were performed via the SOV (14), complete
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Arterial Approach Venous Approach Management
Good outcome 15 43* 5 14 77 (86%)
Poor outcome 021 * 1 04 8 (9%)
Not available 020 * 1 02 5 (5%)
Total 19 44* 72 0 9 0
Note.─ Good outcome = cure or improvement; Poor outcome = aggravation or no change in the symptoms; GK = gamma knife radiation
therapy. 
* = embolization via the venous approach led to a better outcome than via the arterial route (Fisher’s exact test, p = 0.003)CSDAVF obliteration can also be obtained via an
inferior petrosal sinus route which undoubtedly
represents the easiest, shortest, and safest approach
even in patients with inferior petrosal sinus thrombosis
or occlusion. A superior petrosal sinus approach has
been reported to be an alternative to catheterization of
the inferior petrosal sinus (15). As an alternative to the
inferior or superior petrosal sinus pathways, a facial-
ophthalmic route or direct puncture of the SOV may
also be used. Arterial embolization can additionally be
considered in patients in whom venous access is not
possible (16).
Recent studies of the efficacy of stereotactic radiation
have reported complete occlusion in 44-87% of cases,
which is similar to our results (17-19). Advantages of
this technique include decreased invasiveness and
fewer short-term complications, whereas a disadvan-
tage is the delayed response (approximately 6-12
months) after irradiation and possible aggravation of
the symptoms. Therefore, GKR needs to remain the
last treatment option as otherwise the malignant
symptom pattern cannot be managed. The combined
use of GKR and transarterial embolization with
particles can enhance the effectiveness of this
technique and thus reduce the risk of worsening
symptoms during the follow-up period (19-21).
Because of the low prevalence of aggressive
symptoms and the relatively high rates of spontaneous
regression, it is suggested that the majority of cases be
treated conservatively for 1-3 months (2). However,
cases with progressive symptoms and dangerous
drainage patterns require more aggressive treatment
and cases that have remained stable for a few months
should be treated with irradiation or intervention. One
should also be aware that the low-risk drainage patterns
of DAVFs can develop into high-risk patterns with
progressive thrombosis or restriction of the CS outlet
(5, 12, 22).  
In  conclusion,  various  factors  of  the  SxP,
angiographic type, and mode of treatment should all be
considered in order to obtain a more favorable outcome
for CSDAVF. In our study, embolization led to a more
favorable outcome compared to conservative manage-
ment or GKR. Therefore, we also suggest that a
successful outcome can be obtained by embolization
using a venous approach more often than by using an
arterial approach.
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